Deep learning unifies multi-omics for sharper, personalised cancer decisions


 A new study highlighted in GenEngNews showcases the power of Deep Learning (DL) to solve one of oncology's biggest data challenges: fragmentation. Cancer treatment increasingly relies on "multi-omics"—combining data from genomics (DNA), transcriptomics (RNA), and proteomics (proteins). However, integrating these massive, disparate datasets manually is nearly impossible.

The new deep learning framework automates this integration, identifying hidden patterns across the different biological layers that human analysis might miss. By unifying this data, the AI can predict how a specific patient’s tumor will respond to drugs with far greater accuracy than single-layer analysis. This advancement moves precision oncology closer to a reality where treatment plans are custom-built based on the full biological complexity of a patient's cancer.

Read the original article at: https://www.genengnews.com/topics/artificial-intelligence/deep-learning-integrates-multi-omics-for-precision-oncology-decision-making/


Follow us on Instagram, Twitter, and Facebook to stay up to date with what's new in healthcare all around the world.

Comments

Popular posts from this blog

Generative AI Will Transform Healthcare, But Only If We Get the Governance Right

AI in healthcare Insights: 20th November - 26th November' 2025

Clinical AI & MedTech Insights: January 22 - January 28